1932

Abstract

G protein–coupled receptors (GPCRs) are major regulators of intercellular interactions. They initiate these actions by being activated by a wide variety of natural ligands. Historically, ligands were discovered first, but the advent of molecular biology reversed this trend. Most GPCRs are identified on the basis of their DNA sequences and thus are initially unmatched to known natural ligands. They are termed orphan GPCRs. Discovering their ligands—i.e., “deorphanizing” the GPCRs—gave birth to the field of reverse pharmacology. This review discusses the present status of GPCR deorphanization, presents a few examples of successes and surprises, and highlights difficulties encountered in these efforts.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-pharmtox-010611-134548
2013-01-06
2024-04-19
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-pharmtox-010611-134548
Loading
/content/journals/10.1146/annurev-pharmtox-010611-134548
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error